Treatments | Total FA | C16:0 | C18:0 | C18:1 | C18:2 | C18:3 | MDA, μmol/g FW |
---|---|---|---|---|---|---|---|
CK | 19.37c | 3.34 | 1.62 | 2.89c | 9.06d | 1.52c | 68.99a |
BHA50 | 21.81b | 3.36 | 1.65 | 3.06b | 10.73c | 1.65b | 46.69b |
BHA100 | 22.12a | 3.29 | 1.56 | 3.15b | 11.65b | 1.67b | 34.45c |
TBHQ50 | 22.74a | 3.41 | 1.58 | 2.99b | 11.68b | 1.79a | 32.75c |
TBHQ100 | 23.04a | 3.30 | 1.51 | 3.11b | 11.95a | 1.82a | 32.31c |
TPP50 | 22.56a | 3.35 | 1.55 | 3.22b | 11.62b | 1.80a | 32.44c |
TPP100 | 23.05a | 3.22 | 1.50 | 3.56a | 12.02a | 1.85a | 31.82c |
VE50 | 21.95b | 3.38 | 1.60 | 3.02b | 10.69c | 1.63b | 45.68b |
VE100 | 22.74a | 3.25 | 1.57 | 3.23b | 11.33b | 1.72b | 34.12c |
1SEM | 0.65 | 0.17 | 0.09 | 0.27 | 1.33 | 0.12 | 2.41 |